Technical

Technical — The Price Picture

The tape is telling a different story than the income statement. Earnings are steady but the stock has been cut almost in half from its April 2025 peak, dragged down by the July 2025 market-coupling announcement and the January 2026 regulatory aftermath. Price is flirting with its 200-day on the upside for the first time in eight months, RSI just punched through 70, and the MACD histogram has flipped positive. This is a technically troubled chart that has begun to heal — but the overhead supply is heavy and the last death cross has not yet reversed.

1. Price snapshot

IEX sits near the bottom quintile of its 52-week range (21st percentile), still down 27 percent year-on-year despite a 1 percent YTD gain that only recovers the worst of the January flush. Beta is an estimate; the last published NIFTY 50 trailing beta for IEX was around 1.1.

2. The critical chart — full history with 50 and 200-day SMAs

The long arc is clear: a parabolic run from 2020 into the October 2021 all-time high near ₹319, then a multi-year round trip back to the mid ₹100s. The 50-day has just turned up and is closing on the 200-day from below, but hasn't crossed yet. A golden cross would require 50-day to trade above 200-day, which would demand roughly ten more sessions near current levels.

3. Relative strength — IEX rebased vs a NIFTY 50 proxy

Over five years IEX has gone roughly flat at 110, while a NIFTY 50 proxy compounding at 12 percent is near 175. The underperformance opened up decisively after the October 2021 peak and again after the July 2025 regulatory shock. This is secular underperformance versus the broad Indian market, not a recent wobble.

Data note: a benchmark ETF price series was not pre-staged for this run; the grey line is a 12 percent CAGR proxy for NIFTY 50 total return. The visual direction is robust even if the exact level is indicative.

4. Momentum — RSI and MACD

RSI has climbed from the mid-30s in March to 70.0 at the close on 17 April — the upper bound of the neutral band and the first touch of overbought territory since April 2025. MACD histogram has been positive for the last ten sessions and is expanding. Both momentum signals are constructive on the short run; neither has yet shown the multi-month divergence that would mark a durable low.

5. Volume and conviction

All three top volume-spike days cluster around regulatory events: 24 and 25 July 2025 mark the CERC market-coupling announcement and its aftermath (a 30 percent gap down followed by a partial bounce on 17x average volume); 9 January 2026 marks the second leg of regulatory unease. The pattern is distribution, not accumulation — the heavy-volume days were predominantly red or were relief bounces, not breakout sessions.

6. Volatility regime

Ten-year percentile bands (annualized, %): calm at or below 22.9, normal 22.9 to 44.6, stressed above 44.6. Current 30-day realized vol is 36.2 percent — squarely in the normal band but on the elevated side of the median (31.5). The July 2025 spike pushed vol well into the stressed zone; it has since cooled but has not returned to the calm regime that characterized 2023 and early 2024.

7. Technical scorecard and stance

Stance — 3 to 6 month horizon: neutral, tilting bearish. The momentum thaw is real and RSI plus MACD deserve credit, but it is happening into a wall of technical damage: price is still below the 200-day, the August 2025 death cross has not reversed, five-year relative strength is decisively negative, and the volume map reads as distribution around regulatory news, not accumulation. A close above the 200-day at ₹140 that holds for more than ten sessions would be the first serious repair signal and open a path toward the 2025 congestion zone near ₹165. Failure there would retest the January 2026 low near ₹120, below which there is no meaningful support until the 2023 base around ₹100. Trade the range, do not own the trend until price clears ₹140 with volume.